CYP1A2 antibody [15E2]

GeneTex

CYP1A2 antibody [15E2]

9

WB: 1:500. ICC/IF: 1:100. IHC-P: 1:50. FACS: 1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Flow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Monoclonal

0.8 mg/ml

Unconjugated

CYP1A2

cytochrome P450 family 1 subfamily A member 2

CP12, CYPIA2, P3-450, P450(PA), cytochrome P450 1A2, P450 form 4, aryl hydrocarbon hydroxylase, cholesterol 25-hydroxylase, cytochrome P(3)450, cytochrome P450 4, cytochrome P450, family 1, subfamily A, polypeptide 2, cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2, cytochrome P450-P3, dioxin-inducible P3-450, flavoprotein-linked monooxygenase, hydroperoxy icosatetraenoate dehydratase, microsomal monooxygenase, xenobiotic monooxygenase

Mouse

IgG2a

Cytochrome P450 1A2

Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.

-20°C or -80°C,2°C to 8°C

12352203